Indication

Advanced Malignant Solid Tumor of Digestive System

1 clinical trial

1 product

Clinical trial

An Open Label, Dose-escalation and Extension, Phase I Clinical Study on Evaluating Safety, Tolerability and Pharmacodynamics of Intravenous Administration of IDOV-SAFE in Patients With Advanced Malignant Solid Tumors Who Have Failed in Standard Treatment.

Status: Recruiting, Estimated PCD: 2025-11-30

Product